ARCHIVES

NCI Changes Deadlines For Two RFAS

This article is from The Cancer Letter archive.

Vol. 23 No. 28 | July 18, 1997

Download PDF Visit The Full Archive

Related Articles

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991

NCAB Seeks Greater flexibility In Grants Target To Aid P01s

May 31, 1991

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012